(1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide

C36H44N6O8S — CID 45279255

IUPAC(1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
SMILESCOc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6(C)CC6)C[C@H]5/C=C\CCCCO[C@H](C)C(=O)N4C3)cc(-n3ccc(C)n3)nc2c1
InChIInChI=1S/C36H44N6O8S/c1-22-12-15-42(39-22)31-19-30(27-11-10-25(48-4)17-28(27)37-31)50-26-18-29-32(43)38-36(34(45)40-51(46,47)35(3)13-14-35)20-24(36)9-7-5-6-8-16-49-23(2)33(44)41(29)21-26/h7,9-12,15,17,19,23-24,26,29H,5-6,8,13-14,16,18,20-21H2,1-4H3,(H,38,43)(H,40,45)/b9-7-/t23-,24-,26-,29+,36-/m1/s1
InChIKeyPBPIHJKGPGWUHH-UVYVJGLNSA-N
MW720.85 g/mol
LogP3.10
Rot. Bonds7

About (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide

(1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide (PubChem CID 45279255) has the molecular formula C36H44N6O8S and a molecular weight of 720.85 g/mol. Its IUPAC name is (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide.

Molecular Properties

Compound Name(1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
PubChem CID45279255
Molecular FormulaC36H44N6O8S
Molecular Weight720.85 g/mol
Exact Mass720.29
IUPAC Name(1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
SMILESCOc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6(C)CC6)C[C@H]5/C=C\CCCCO[C@H](C)C(=O)N4C3)cc(-n3ccc(C)n3)nc2c1
InChIInChI=1S/C36H44N6O8S/c1-22-12-15-42(39-22)31-19-30(27-11-10-25(48-4)17-28(27)37-31)50-26-18-29-32(43)38-36(34(45)40-51(46,47)35(3)13-14-35)20-24(36)9-7-5-6-8-16-49-23(2)33(44)41(29)21-26/h7,9-12,15,17,19,23-24,26,29H,5-6,8,13-14,16,18,20-21H2,1-4H3,(H,38,43)(H,40,45)/b9-7-/t23-,24-,26-,29+,36-/m1/s1
InChIKeyPBPIHJKGPGWUHH-UVYVJGLNSA-N
XLogP3.10
TPSA171.05 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500720.85
LogP ≤ 53.10
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide?
The IUPAC name of (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide (CID 45279255) is (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide.
What is the SMILES notation for (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide?
The canonical SMILES for (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide is COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6(C)CC6)C[C@H]5/C=C\CCCCO[C@H](C)C(=O)N4C3)cc(-n3ccc(C)n3)nc2c1.
What is the InChIKey of (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide?
The InChIKey is PBPIHJKGPGWUHH-UVYVJGLNSA-N. The full InChI is InChI=1S/C36H44N6O8S/c1-22-12-15-42(39-22)31-19-30(27-11-10-25(48-4)17-28(27)37-31)50-26-18-29-32(43)38-36(34(45)40-51(46,47)35(3)13-14-35)20-24(36)9-7-5-6-8-16-49-23(2)33(44)41(29)21-26/h7,9-12,15,17,19,23-24,26,29H,5-6,8,13-14,16,18,20-21H2,1-4H3,(H,38,43)(H,40,45)/b9-7-/t23-,24-,26-,29+,36-/m1/s1.
What are the key properties of (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide?
(1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide has a molecular weight of 720.85 g/mol, XLogP of 3.10, 7 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,4R,6S,7Z,14R,18R)-18-[7-methoxy-2-(3-methylpyrazol-1-yl)quinolin-4-yl]oxy-14-methyl-N-(1-methylcyclopropyl)sulfonyl-2,15-dioxo-13-oxa-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide is sourced from PubChem (CID 45279255), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).